Organs-on-chips Market Trends

Organs-on-chips Market Trends

The rising prevalence of chronic diseases is increasing the need for rapid drug discovery methods, driving the necessity for drug toxicity identification, technological progress, and the introduction of new products by major market players. For instance, Emulate Inc.'s alveolus lung-chip and airway lung-chip models, helped in COVID-19 research. These innovative organ-on-chip technologies supported in enhancing the early infectious disease clinical studies for expediting the pandemic research efforts. 
 

The growing advancement and the support by regulatory authorities are accelerating the development and adoption of advanced organ-on-chip technologies. For instance, in January 2023, FDA Modernization Act 2.0 approval aimed to accelerate the organ-on-chip integration in pharmaceuticals, using innovations in testing methods for ethical and streamlined drug development. Advanced technologies are providing an opportunity for the pharmaceutical industry to expedite drug development while reducing reliance on animal studies.